Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1998
03/12/1998WO1998009981A1 Human salivary proteins and fragments thereof having alpha-glucosidase inhibitory activity
03/12/1998WO1998009980A1 Bh3 interacting domain death agonist
03/12/1998WO1998009979A1 Lipid metabolic pathway compositions and therapeutic and diagnostic uses therefor
03/12/1998WO1998009657A2 Method for recombinant adeno-associated virus-directed gene therapy
03/12/1998WO1998009655A1 Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene
03/12/1998WO1998009651A1 ANTI-INTEGRIN α3 ANTIBODY COMPLEXES
03/12/1998WO1998009649A1 Inhibition of viral replication
03/12/1998WO1998009645A1 Peptide-containing drug compositions for oral administration
03/12/1998WO1998009644A2 Method for lowering cholesterol levels
03/12/1998WO1998009643A1 Modulation of apoptosis by serine phosphorylation of blc-xl/blc-2 associated cell death regulator
03/12/1998WO1998009642A2 Therapeutic chemokine antagonists
03/12/1998WO1998009641A1 Semipeptoid farnesyl protein transferase inhibitors and analogs thereof
03/12/1998WO1998009640A1 Antiviral treatment
03/12/1998WO1998009639A1 Novel bacteriocins, transport and vector system and method of use thereof
03/12/1998WO1998009638A1 INHIBITION OF MAST CELL ACTIVATION BY gp49-BASED MECHANISMS AND REAGENTS
03/12/1998WO1998009634A1 Nad or nadp containing pharmaceutical compositions for treating aids
03/12/1998WO1998009620A1 INHIBITION OF NUCLEAR TRANSCRIPTION FACTOR NF-λB BY CAFFEIC ACID PHENETHYL ESTER (CAPE), DERIVATIVES OF CAPE, CAPSAICIN (8-METHYL-N-VANILLYL-6-NONENAMIDE) AND RESINIFERATOXIN
03/12/1998WO1998009614A1 Hydrogel base permeable device containing live cells, and its applications
03/12/1998WO1998009613A1 Process to manufacture implants containing bioactive peptides
03/12/1998WO1998009602A2 Anti-atherosclerotic peptides and a transgenic mouse model of atherosclerosis
03/12/1998WO1998009523A1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
03/12/1998WO1998009522A1 Insecticidal peptides from segestria sp. spider venom
03/12/1998WO1998005792A3 A novel human leptin receptor gene-related protein
03/12/1998WO1998004712A3 Substrate trapping protein tyrosine phosphatases
03/12/1998WO1998004709A3 Herpes simplex virus ICP4 is an inhibitor of apoptosis
03/12/1998WO1998004585A3 Novel human macrophage antigen
03/12/1998WO1998003872A3 Immunological process for detecting antibodies directed towards tissue transglutaminase (ttg), use of ttg for diagnostic purposes and therapy control, and oral pharmaceutical agent containing ttg
03/12/1998WO1998001563A3 Adenovirus e4 proteins for inducing cell death
03/12/1998WO1998000552A3 Receptor tyrosine phosphatase, and uses related thereto
03/12/1998WO1997049827A3 Adenoviral mediated gene transfer in adipocytes and related implants
03/12/1998WO1997046682A3 Polynucleotides from human adult PBMC encoding secreted proteins
03/12/1998WO1997046661A3 A human radioresistance/cell cycle progression gene
03/12/1998WO1997046259A3 Chimeric toxin for targeted therapy
03/12/1998WO1997041895A3 TREATMENT OF ASTHMA WITH TNFR-Ig
03/12/1998WO1997040854A3 Polypeptide conjugates for transporting substances across cell membranes
03/12/1998DE19638745A1 Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR) Monoclonal antibodies against the extracellular domain of the human VEGF - receptor protein (KDR)
03/12/1998DE19636889A1 Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel Antineoplastic acting transferrin and albumin conjugates cytostatic compounds from the group of anthracyclines, alkylating agents, antimetabolites and cisplatin analogues and pharmaceutical compositions containing them
03/12/1998DE19636623A1 New acyl-(aryl- or hetero-aryl(carbonyl))aminoacid compounds
03/12/1998CA2718347A1 Gene therapy for congestive heart failure
03/12/1998CA2639051A1 Fungal antigens and process for producing the same
03/12/1998CA2279651A1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
03/12/1998CA2265890A1 The use of muramylpeptides in the treatment of myelosuppressed or otherwise immunocompromised states
03/12/1998CA2265889A1 E25a protein, methods for production and use thereof
03/12/1998CA2264965A1 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
03/12/1998CA2264959A1 Central nervous system-derived immune privilege factor and uses thereof
03/12/1998CA2264956A1 Herpesvirus saimiri as viral vector
03/12/1998CA2264926A1 Antiviral treatment
03/12/1998CA2264918A1 Method for lowering cholesterol levels
03/12/1998CA2264845A1 Novel bacteriocins, transport and vector system and method of use thereof
03/12/1998CA2264578A1 Bh3 interacting domain death agonist
03/12/1998CA2264493A1 Human homolog of the latheo gene
03/12/1998CA2264490A1 Htm4, methods of treatment and assays, agonists and antagonists
03/12/1998CA2264485A1 Gata-6 transcription factor: compositions and methods
03/12/1998CA2264285A1 Anti-inflammatory peptides and uses thereof
03/12/1998CA2259969A1 Phospholipase d and dna sequences
03/12/1998CA2259959A1 Modulators of brca1 activity
03/12/1998CA2248001A1 Treatment of antigen presenting cells to modulate antigen presenting cell function
03/12/1998CA2236595A1 Process to manufacture implants containing bioactive peptides
03/12/1998CA2215015A1 Treating prostate hypertrophy and prostate cancer
03/11/1998EP0828003A2 Human serine protease
03/11/1998EP0827968A2 Bioactive substance having antitumor activity, producing strain, production ans use thereof
03/11/1998EP0827751A2 Medicinal composition containing tissue plasminogen activator and nicotinamide
03/11/1998EP0827750A2 Obesity protein formulations
03/11/1998EP0827749A2 Peritoneal dialysis solution
03/11/1998EP0827748A2 Peritoneal dialysis solution
03/11/1998EP0827745A1 Anti-tumour compositions containing taxan derivatives
03/11/1998EP0827743A1 Use of histone decarboxylase inhibitors for treating fibrosis
03/11/1998EP0827742A1 Use of histone deacetylase inhibitors for treating fribosis or cirrhosis
03/11/1998EP0827546A2 Gene therapy using replication competent targeted adenoviral vectors
03/11/1998EP0827544A2 Multimeric proteins
03/11/1998EP0827539A2 Kunitz type protease inhibitors
03/11/1998EP0827538A1 Novel variants of apolipoprotein a-i
03/11/1998EP0827537A2 Chromatin-regulator genes
03/11/1998EP0827511A1 Agents for binding to advanced glycosylation endproducts, and methods of their use
03/11/1998EP0827509A1 Modulation of cholesteryl ester transfer protein (cetp) activity
03/11/1998EP0827412A1 Peptide radiopharmaceutical applications
03/11/1998EP0827409A1 Compositions and methods for inhibiting xenograft rejection
03/11/1998EP0827408A1 Method of administration of igf-i
03/11/1998EP0827407A1 POST-TRANSLATIONAL ACTIVATION OF TGF-$g(b) 1? INVOLVING THE TSP-1 RECEPTOR CD36
03/11/1998EP0827396A1 Production scale method of forming microparticles
03/11/1998EP0696919A4 Diagnosis and treatment of erectile dysfunction
03/11/1998EP0666757B1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins
03/11/1998EP0660717B1 Aminosteroids for ophthalmic use
03/11/1998EP0656785B1 Method for inhibiting hiv replication using il-4
03/11/1998EP0556178B1 Use of protease nexin-i to mediate wound healing
03/11/1998EP0552188B1 Treatment of tumorigenic pathophysiological conditions with fgf-cytotoxic conjugates
03/11/1998EP0503002B1 Antisense oligonucleotide inhibition of papillomavirus
03/11/1998CN1175977A Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw* 1601 and uses thereof
03/11/1998CN1175958A Monoclonal antiidiotypic antibodies (AB2) and uses thereof
03/11/1998CN1175957A Monoclonal antibodies anti-CD6 and their uses
03/11/1998CN1175956A Novel protein and method for production of same
03/11/1998CN1175954A Isolated nonapeptides presented by HLA molecules, and uses thereof
03/11/1998CN1175953A Novel dipeptide amidines as thrombin inhibitors
03/11/1998CN1175902A Method and compositions for lipidization of hydrophilic molecules
03/11/1998CN1175465A Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates
03/10/1998US5726319 Biphenyl substituted dipeptide analogs promote release of growth hormone
03/10/1998US5726304 Porphocyanine and CNC-expanded porphyrins
03/10/1998US5726298 Epimorphin and its encoding nucleic acids
03/10/1998US5726291 Amylase inhibitors
03/10/1998US5726290 Soluble analogues of integrins
1 ... 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 2655 2656 2657 2658 2659 2660 2661 2662 2663 2664 ... 3163